Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    2 0 0 0


Archives de pédiatrie
Volume 20, n° 4
pages 428-429 (avril 2013)
Doi : 10.1016/j.arcped.2013.01.044
Éverolimus chez des patients atteints d’astrocytomes sous épendymaires à cellules géantes (SEGA) associés à une sclérose tubéreuse de Bourneville (STB) en France : résultats préliminaires. Étude européenne Effects
 

J.-M. Pedespan a, d, A. De Saint Martin b, d, F. Audic-Gerard c, d, C. Cances c, d, P. Chastagner d, e, M. Milh d, c, S. Nguyen The Tich d, f, A. Riquet d, g, L. Vallée d, g, F. Fardao-Beyler d, h, , R. Nabbout d, i
a CHU de Pellegrin, Bordeaux, France 
b Hôpital Hautepierre, Strasbourg, France 
c Hôpital des Enfants, Toulouse, France 
d Hôpital d’enfants de La Timone, Marseille, France 
e Hôpital Brabois enfants, Vandœuvre Les Nancy, France 
f CHU d’Angers, Angers, France 
g Hôpital Roger Salengro, Lille, France 
h Novartis, Rueil Malmaison, France 
i Hôpital Necker, Paris, France 

Auteur correspondant.


© 2013  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@